Sponsor:
VA Office of Research and Development
Code:
NCT05897021
Conditions
Depressive Symptoms
Anxiety
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Expressive Writing on Minority Stressors
Neutral Writing
Brief summary:
Conditions
Depressive Symptoms
Anxiety
Study ID
NCT05897021
Start date
Mar 20, 2024
Status verified date
Jan, 2026
Completion date
Sep 30, 2028
Anticipated
Primary completion date
Oct 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
85 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Expressive Writing on Minority Stressors
placebo comparator: Neutral Writing
Interventions
Expressive Writing on Minority Stressors
Neutral Writing
Primary outcome measure
Central contacts
Locations
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Recruiting
Boston, Massachusetts, United States, 02130-4817
Contacts
Principal Investigator:
Kelly L Harper, PhD
Sponsor
VA Office of Research and Development
Last update posted
Feb 2, 2026
Last verified
Jan, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by VA Office of Research and Development on 2026-02-02.